Huberman Lab cover image

Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders

Huberman Lab

CHAPTER

Navigating Psychedelic Clinical Trials

This chapter explores the intricacies of participating in clinical trials for psychedelics, focusing on the preparatory steps and screening criteria. It addresses the unpredictability of experiences, the effects of psilocybin, and the nuances between microdosing and macrodosing, while also examining the pharmacological interactions of various compounds.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner